Cargando…
Pharmacogenetic Tests in Reducing Accesses to Emergency Services and Days of Hospitalization in Bipolar Disorder: A 2-Year Mirror Analysis
Despite the enormous costs associated to mood disorders’, few studies evaluate potential cost saving from the use of pharmacogenetic tests (PGT). This study compares 12 months before the execution of the PGT versus 12 months after, in terms of number and days of hospitalization and accesses to emerg...
Autores principales: | Callegari, Camilla, Isella, Celeste, Caselli, Ivano, Poloni, Nicola, Ielmini, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617043/ https://www.ncbi.nlm.nih.gov/pubmed/31052247 http://dx.doi.org/10.3390/jpm9020022 |
Ejemplares similares
-
The utility of pharmacogenetic testing to support the treatment of bipolar disorder
por: Ielmini, Marta, et al.
Publicado: (2018) -
Medically Unexplained Physical Symptoms in Hospitalized Patients: A 9-Year Retrospective Observational Study
por: Poloni, Nicola, et al.
Publicado: (2018) -
Pharmacogenetic Testing in Acute and Chronic Pain: A Preliminary Study
por: Panella, Lorenzo, et al.
Publicado: (2019) -
Hospitalized Patients with Medically Unexplained Physical Symptoms: Clinical Context and Economic Costs of Healthcare Management
por: Poloni, Nicola, et al.
Publicado: (2019) -
Epidemiology and evolution of the diagnostic classification of factitious disorders in DSM-5
por: Caselli, Ivano, et al.
Publicado: (2017)